Figure 5: Changes in SF-36 from baseline values after administration of Kampo formulae. The influence of the Kampo formulae on patients’ QOL was evaluated by changes in SF-36 from baseline to the end of administration. Differences in influence on the scores of SF-36 between the formulae are shown. Data are means (dots) and 95% confidence intervals (bars). Bakumondo-to significantly improved patients’ QOL in the context of vitality, whereas Hochu-ekki-to significantly impaired patients’ QOL in the context of physical functioning and vitality, compared with other formulae. by ANOVA with Bonferroni correction.